Wednesday, December 18, 2013

Interesting news tidbit

Don't know what to think of it, but from the inbox, a (lightly edited) comment from a reader in India:
After shutting down CNS in US, Biocon Bristol Myers-Squibb Research Centre (BBRC) Bangalore, India has laid off about 30% of its work force in medicinal chemistry including the director. This centre was CNS centric, most of the work was on CNS diseases.
Anyone else have a similar story to report?  

5 comments:

  1. True, More are coming. It seems CNS, Diabetes and Virology are hit badly at India Centre. With Diabetes sold to AZ, It seems BMS will bail out of India R & D.

    ReplyDelete
  2. Great! A new supply of cheap highly skilled Indian post-docs to tap into for US academia! I'm saved!

    ReplyDelete
  3. Who really cares about someone in India losing his job?

    ReplyDelete
  4. Any one who loses job is a sad news.
    Important news is that BMS is cutting Job all over.
    What they are upto?

    ReplyDelete
  5. Lol!! Its been a long time since I've heard "rumint" and it was never outside of the intel community! :D

    ReplyDelete